- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
The worldwide market for Drug Eluting Balloon for Peripheral Artery Disease is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Drug Eluting Balloon for Peripheral Artery Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Cook Group
Bayer
BD
Medtronic
Opto Circuits
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
3μg/ mm2
2μg/ mm2
Others
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Balloon for Peripheral Artery Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Eluting Balloon for Peripheral Artery Disease, with price, sales, revenue and global market share of Drug Eluting Balloon for Peripheral Artery Disease in 2017 and 2018.
Chapter 3, the Drug Eluting Balloon for Peripheral Artery Disease competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Balloon for Peripheral Artery Disease breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Drug Eluting Balloon for Peripheral Artery Disease market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Drug Eluting Balloon for Peripheral Artery Disease sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Drug Eluting Balloon for Peripheral Artery Disease Introduction
1.2 Market Analysis by Type
1.2.1 3μg/ mm2
1.2.2 2μg/ mm2
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Ambulatory Surgery Centers
1.3.3 Catheterization Laboratories
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cook Group
2.1.1 Business Overview
2.1.2 Drug Eluting Balloon for Peripheral Artery Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cook Group Drug Eluting Balloon for Peripheral Artery Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Drug Eluting Balloon for Peripheral Artery Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Drug Eluting Balloon for Peripheral Artery Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 BD
2.3.1 Business Overview
2.3.2 Drug Eluting Balloon for Peripheral Artery Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Medtronic
2.4.1 Business Overview
2.4.2 Drug Eluting Balloon for Peripheral Artery Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Opto Circuits
2.5.1 Business Overview
2.5.2 Drug Eluting Balloon for Peripheral Artery Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Opto Circuits Drug Eluting Balloon for Peripheral Artery Disease Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Drug Eluting Balloon for Peripheral Artery Disease Manufacturer Market Share in 2018
3.3.2 Top 6 Drug Eluting Balloon for Peripheral Artery Disease Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Drug Eluting Balloon for Peripheral Artery Disease Market Analysis by Regions
4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Regions
4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Regions (2014-2019)
4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Regions (2014-2019)
4.2 North America Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
4.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
4.5 South America Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
5 North America Drug Eluting Balloon for Peripheral Artery Disease by Country
5.1 North America Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Country
5.1.1 North America Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Country (2014-2019)
5.1.2 North America Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Country (2014-2019)
5.2 United States Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
5.3 Canada Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
5.4 Mexico Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
6 Europe Drug Eluting Balloon for Peripheral Artery Disease by Country
6.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Country
6.1.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Country (2014-2019)
6.1.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Country (2014-2019)
6.2 Germany Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
6.3 UK Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
6.4 France Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
6.5 Russia Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
6.6 Italy Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
7 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease by Country
7.1 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Country (2014-2019)
7.2 China Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
7.3 Japan Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
7.4 Korea Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
7.5 India Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
8 South America Drug Eluting Balloon for Peripheral Artery Disease by Country
8.1 South America Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Country
8.1.1 South America Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Country (2014-2019)
8.1.2 South America Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Country (2014-2019)
8.2 Brazil Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
8.3 Argentina Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
8.4 Colombia Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
9 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease by Countries
9.1 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
9.3 Turkey Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
9.4 Egypt Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
9.5 Nigeria Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
9.6 South Africa Drug Eluting Balloon for Peripheral Artery Disease Sales and Growth Rate (2014-2019)
10 Global Drug Eluting Balloon for Peripheral Artery Disease Market Segment by Type
10.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales and Market Share by Type (2014-2019)
10.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Type (2014-2019)
10.2 3μg/ mm2 Sales Growth and Price
10.2.1 Global 3μg/ mm2 Sales Growth (2014-2019)
10.2.2 Global 3μg/ mm2 Price (2014-2019)
10.3 2μg/ mm2 Sales Growth and Price
10.3.1 Global 2μg/ mm2 Sales Growth (2014-2019)
10.3.2 Global 2μg/ mm2 Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Drug Eluting Balloon for Peripheral Artery Disease Market Segment by Application
11.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Ambulatory Surgery Centers Sales Growth (2014-2019)
11.4 Catheterization Laboratories Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Drug Eluting Balloon for Peripheral Artery Disease Market Forecast (2019-2024)
12.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue and Growth Rate (2019-2024)
12.2 Drug Eluting Balloon for Peripheral Artery Disease Market Forecast by Regions (2019-2024)
12.2.1 North America Drug Eluting Balloon for Peripheral Artery Disease Market Forecast (2019-2024)
12.2.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Market Forecast (2019-2024)
12.2.3 Asia-Pacific Drug Eluting Balloon for Peripheral Artery Disease Market Forecast (2019-2024)
12.2.4 South America Drug Eluting Balloon for Peripheral Artery Disease Market Forecast (2019-2024)
12.2.5 Middle East and Africa Drug Eluting Balloon for Peripheral Artery Disease Market Forecast (2019-2024)
12.3 Drug Eluting Balloon for Peripheral Artery Disease Market Forecast by Type (2019-2024)
12.3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Type (2019-2024)
12.3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Market Share Forecast by Type (2019-2024)
12.4 Drug Eluting Balloon for Peripheral Artery Disease Market Forecast by Application (2019-2024)
12.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Application (2019-2024)
12.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Drug Eluting Balloon for Peripheral Artery Disease Picture
Table Product Specifications of Drug Eluting Balloon for Peripheral Artery Disease
Figure Global Sales Mar
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
